Newsletter
Issue #7: The GLP-1 Gold Rush
The fastest-growing drug class in history costs 3-5x more in America. We modeled what happens when Medicare starts paying.
Newsletter
The fastest-growing drug class in history costs 3-5x more in America. We modeled what happens when Medicare starts paying.
Newsletter
Original analysis of 5,480 hospitals reveals $28 billion in addressable supply waste
Newsletter
How $200 billion a year in billing complexity and administrative overhead inflates U.S. healthcare costs
Newsletter
How Pharmacy Benefit Managers extract $30 billion a year from the drug supply chain, and what to do about it
Newsletter
Why a hip replacement costs $29,000 in America and $10,000 almost everywhere else
Newsletter
Why nine top-spend Medicare drugs cost up to 581x more in America than abroad
Newsletter
How Medicare Part D overpays for brand drugs with cheaper over-the-counter equivalents